NEW YORK, Aug 9 (Reuters) - U.S. biotechnology company Genzyme Corp said on Thursday it reached an agreement in principle to settle a shareholder class-action lawsuit for $64 million. Under the terms ...
NEW YORK (CBS.MW) -- Genzyme said a Massachusetts Superior Court judge has thrown out a lawsuit brought against the biotech company by Biosurgery division shareholders relating to Genzyme's decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results